Filed: 5/14/2026ACC: 0001931118-26-000008
📋 What this filing means
SUPERSTRING CAPITAL MANAGEMENT LP filed this quarterly 13F‑HR report disclosing 35 equity positions with a total reported market value of $139.97M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
35
Positions
$139.97M
Total AUM (reported)
9.57M
Total Shares
Allocation by class
COM$110.02M78.6%
COM NEW$8.18M5.8%
SPONSORED ADS$8.15M5.8%
COM SHS$7.80M5.6%
ADR$5.19M3.7%
COM STK$632.8K0.5%
Portfolio Concentration
Top 3$34.48M24.6%
4–10$46.60M33.3%
11–25$50.40M36.0%
Rest$8.50M6.1%
Top 3 weight
24.6%
Top 10 weight
57.9%
Voting Authority Distribution
Total shares with voting rights: 9.57M
Sole
Full voting authority
9.57M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole35
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings35
Rows:
SUMMIT THERAPEUTICS INC
SOLEShares892.87K
TypeSH
Market value$16.93M
12.09%
Sole
892.87K
Shared
0.00
None
0.00
IMMUNOVANT INC
SOLEShares357.61K
TypeSH
Market value$8.88M
6.35%
Sole
357.61K
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares225.16K
TypeSH
Market value$8.67M
6.19%
Sole
225.16K
Shared
0.00
None
0.00
SAVARA INC
SOLEShares1.59M
TypeSH
Market value$8.66M
6.19%
Sole
1.59M
Shared
0.00
None
0.00
UROGEN PHARMA LTD
SOLEShares387.37K
TypeSH
Market value$6.96M
4.98%
Sole
387.37K
Shared
0.00
None
0.00
DEFINIUM THERAPEUTICS INC
SOLEShares351.46K
TypeSH
Market value$6.64M
4.75%
Sole
351.46K
Shared
0.00
None
0.00
VIR BIOTECHNOLOGY INC
SOLEShares730.55K
TypeSH
Market value$6.55M
4.68%
Sole
730.55K
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares110.45K
TypeSH
Market value$6.42M
4.59%
Sole
110.45K
Shared
0.00
None
0.00
CELLDEX THERAPEUTICS INC NEW
SOLEShares180.05K
TypeSH
Market value$5.71M
4.08%
Sole
180.05K
Shared
0.00
None
0.00
SIONNA THERAPEUTICS INC
SOLEShares141.02K
TypeSH
Market value$5.65M
4.04%
Sole
141.02K
Shared
0.00
None
0.00
GENMAB A/S
SOLEShares196.71K
TypeSH
Market value$5.28M
3.77%
Sole
196.71K
Shared
0.00
None
0.00
ZAI LAB LTD
SOLEShares275.82K
TypeSH
Market value$5.19M
3.71%
Sole
275.82K
Shared
0.00
None
0.00
VERTEX PHARMACEUTICALS INC
SOLEShares11.01K
TypeSH
Market value$4.92M
3.51%
Sole
11.01K
Shared
0.00
None
0.00
IQVIA HLDGS INC
SOLEShares25.67K
TypeSH
Market value$4.38M
3.13%
Sole
25.67K
Shared
0.00
None
0.00
MAPLIGHT THERAPEUTICS INC
SOLEShares192.14K
TypeSH
Market value$3.91M
2.79%
Sole
192.14K
Shared
0.00
None
0.00
ARVINAS INC
SOLEShares312.62K
TypeSH
Market value$3.31M
2.37%
Sole
312.62K
Shared
0.00
None
0.00
ORUKA THERAPEUTICS INC
SOLEShares63.59K
TypeSH
Market value$3.12M
2.23%
Sole
63.59K
Shared
0.00
None
0.00
UNITED THERAPEUTICS CORP DEL
SOLEShares5.19K
TypeSH
Market value$3.08M
2.20%
Sole
5.19K
Shared
0.00
None
0.00
TRAVERE THERAPEUTICS INC
SOLEShares102.75K
TypeSH
Market value$3.05M
2.18%
Sole
102.75K
Shared
0.00
None
0.00
TREVI THERAPEUTICS INC
SOLEShares251.57K
TypeSH
Market value$3.00M
2.14%
Sole
251.57K
Shared
0.00
None
0.00
ADLAI NORTYE LTD
SOLEShares414.85K
TypeSH
Market value$2.87M
2.05%
Sole
414.85K
Shared
0.00
None
0.00
CABALETTA BIO INC
SOLEShares1.07M
TypeSH
Market value$2.87M
2.05%
Sole
1.07M
Shared
0.00
None
0.00
PFIZER INC
SOLEShares74K
TypeSH
Market value$2.08M
1.48%
Sole
74K
Shared
0.00
None
0.00
AXSOME THERAPEUTICS INC.
SOLEShares11.22K
TypeSH
Market value$1.90M
1.35%
Sole
11.22K
Shared
0.00
None
0.00
ORIC PHARMACEUTICALS INC
SOLEShares115.23K
TypeSH
Market value$1.46M
1.04%
Sole
115.23K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SUMMIT THERAPEUTICS INCSOLE | COM | 892.87K | SH | $16.93M 12.09% | 892.87K | 0.00 | 0.00 |
IMMUNOVANT INCSOLE | COM | 357.61K | SH | $8.88M 6.35% | 357.61K | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 225.16K | SH | $8.67M 6.19% | 225.16K | 0.00 | 0.00 |
SAVARA INCSOLE | COM | 1.59M | SH | $8.66M 6.19% | 1.59M | 0.00 | 0.00 |
UROGEN PHARMA LTDSOLE | COM | 387.37K | SH | $6.96M 4.98% | 387.37K | 0.00 | 0.00 |
DEFINIUM THERAPEUTICS INCSOLE | COM SHS | 351.46K | SH | $6.64M 4.75% | 351.46K | 0.00 | 0.00 |
VIR BIOTECHNOLOGY INCSOLE | COM | 730.55K | SH | $6.55M 4.68% | 730.55K | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 110.45K | SH | $6.42M 4.59% | 110.45K | 0.00 | 0.00 |
CELLDEX THERAPEUTICS INC NEWSOLE | COM NEW | 180.05K | SH | $5.71M 4.08% | 180.05K | 0.00 | 0.00 |
SIONNA THERAPEUTICS INCSOLE | COM | 141.02K | SH | $5.65M 4.04% | 141.02K | 0.00 | 0.00 |
GENMAB A/SSOLE | SPONSORED ADS | 196.71K | SH | $5.28M 3.77% | 196.71K | 0.00 | 0.00 |
ZAI LAB LTDSOLE | ADR | 275.82K | SH | $5.19M 3.71% | 275.82K | 0.00 | 0.00 |
VERTEX PHARMACEUTICALS INCSOLE | COM | 11.01K | SH | $4.92M 3.51% | 11.01K | 0.00 | 0.00 |
IQVIA HLDGS INCSOLE | COM | 25.67K | SH | $4.38M 3.13% | 25.67K | 0.00 | 0.00 |
MAPLIGHT THERAPEUTICS INCSOLE | COM | 192.14K | SH | $3.91M 2.79% | 192.14K | 0.00 | 0.00 |
ARVINAS INCSOLE | COM | 312.62K | SH | $3.31M 2.37% | 312.62K | 0.00 | 0.00 |
ORUKA THERAPEUTICS INCSOLE | COM | 63.59K | SH | $3.12M 2.23% | 63.59K | 0.00 | 0.00 |
UNITED THERAPEUTICS CORP DELSOLE | COM | 5.19K | SH | $3.08M 2.20% | 5.19K | 0.00 | 0.00 |
TRAVERE THERAPEUTICS INCSOLE | COM | 102.75K | SH | $3.05M 2.18% | 102.75K | 0.00 | 0.00 |
TREVI THERAPEUTICS INCSOLE | COM | 251.57K | SH | $3.00M 2.14% | 251.57K | 0.00 | 0.00 |
ADLAI NORTYE LTDSOLE | SPONSORED ADS | 414.85K | SH | $2.87M 2.05% | 414.85K | 0.00 | 0.00 |
CABALETTA BIO INCSOLE | COM | 1.07M | SH | $2.87M 2.05% | 1.07M | 0.00 | 0.00 |
PFIZER INCSOLE | COM | 74K | SH | $2.08M 1.48% | 74K | 0.00 | 0.00 |
AXSOME THERAPEUTICS INC.SOLE | COM | 11.22K | SH | $1.90M 1.35% | 11.22K | 0.00 | 0.00 |
ORIC PHARMACEUTICALS INCSOLE | COM | 115.23K | SH | $1.46M 1.04% | 115.23K | 0.00 | 0.00 |
Page 1 of 2